Literature DB >> 3397740

Prolonged suppression of infection in total hip arthroplasty.

J A Goulet1, P M Pellicci, B D Brause, E M Salvati.   

Abstract

Nineteen periprosthetic infections after total hip arthroplasty were treated with prolonged suppressive antibiotics without removing the components. In 11, antibiotic therapy was monitored with serum bactericidal titers. Eleven had incision and drainage. Indications included patients' refusal of removal or medical contraindications to surgery. Requirements included well-fixed components, highly sensitive organisms, and no systemic sepsis. The follow-up period averaged 4.1 years after treatment. Nine hips showed no deterioration. Seven prostheses failed, five with progressive hip sepsis. Three patients had increasing symptoms without prosthesis removal. Although two-stage reimplantation is preferred, suppressive antibiotics and prosthesis retention can succeed in some patients and may be considered in old, frail patients with an early infection caused by bacteria responsive to oral antibiotic therapy. Suppressive therapy may also be considered for an otherwise compliant patient who refuses removal of an infected prosthesis. The organism must be sensitive to oral antibiotics, and the patient must be tolerant of the antibiotics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397740     DOI: 10.1016/s0883-5403(88)80075-5

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  15 in total

1.  Treatment Options for Orthopedic Device-related Infections.

Authors:  Edna Toubes; John Segreti
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

Review 2.  [Guidelines on antimicrobial therapy in situations of periprosthetic THR infection].

Authors:  L Frommelt
Journal:  Orthopade       Date:  2004-07       Impact factor: 1.087

3.  Bone and joint infections.

Authors:  T Louie
Journal:  Can J Infect Dis       Date:  1992-03

4.  Brucellar prosthetic arthritis in a total knee replacement.

Authors:  A Ortí; P Roig; R Alcalá; V Navarro; M Salavert; C Martín; A Zorraquino; J Merino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

Review 5.  Two-Stage Revision Arthroplasty for the Treatment of Prosthetic Joint Infection.

Authors:  Ryan S Charette; Christopher M Melnic
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

6.  Two-stage revision of infected shoulder arthroplasty using prosthesis of antibiotic-loaded acrylic cement: minimum three-year follow-up.

Authors:  Sung Hyun Lee; Se Jin Kim; Seng Hwan Kook; Jeong Woo Kim
Journal:  Int Orthop       Date:  2017-12-02       Impact factor: 3.075

7.  Prolonged suppressive antibiotic therapy is successful in the management of prosthetic joint infection.

Authors:  N A Sandiford; J R Hutt; D O Kendoff; P A Mitchell; M Citak; L Granger
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-10-01

8.  Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection?

Authors:  Fay Leung; Corey J Richards; Donald S Garbuz; Bassam A Masri; Clive P Duncan
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

9.  Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study.

Authors:  V Prendki; T Ferry; P Sergent; E Oziol; E Forestier; T Fraisse; S Tounes; S Ansart; J Gaillat; S Bayle; O Ruyer; F Borlot; G Le Falher; B Simorre; F-A Dauchy; S Greffe; T Bauer; E N Bell; B Martha; M Martinot; M Froidure; M Buisson; A Waldner; X Lemaire; A Bosseray; M Maillet; V Charvet; A Barrelet; B Wyplosz; M Noaillon; E Denes; E Beretti; M Berlioz-Thibal; V Meyssonnier; E Fourniols; L Tliba; A Eden; M Jean; C Arvieux; K Guignery-Kadri; C Ronde-Oustau; Y Hansmann; A Belkacem; F Bouchand; G Gavazzi; F Herrmann; J Stirnemann; A Dinh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-04       Impact factor: 3.267

Review 10.  [Diagnosis and treatment of foreign-body-associated infection in orthopaedic surgery].

Authors:  L Frommelt
Journal:  Orthopade       Date:  2009-09-06       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.